Wen-Cheng Chang Selected Research

Wen-Cheng Chang Research Topics

27	Neoplasms (Cancer) 07/2022 - 01/2004
4	Death (Near-Death Experience) 01/2022 - 04/2012
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2008 - 10/2002
2	Hypersensitivity (Allergy) 01/2021 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2016 - 12/2004
2	Adenocarcinoma of Lung 12/2007 - 12/2004
1	Aspiration Pneumonia 01/2023
1	Esophageal Neoplasms (Esophageal Cancer) 01/2023
1	Deglutition Disorders (Dysphagia) 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 12/2022
1	Liver Diseases (Liver Disease) 12/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Brain Hypoxia (Cerebral Hypoxia) 01/2022
1	Prolonged Grief Disorder 01/2022
1	Chronic Hepatitis C 01/2022
1	Merkel Cell Carcinoma 12/2021
1	Drug Hypersensitivity (Drug Allergy) 01/2021
1	Cardiotoxicity 10/2020
1	Acute Generalized Exanthematous Pustulosis 01/2018
1	Exanthema (Rash) 01/2018
1	Eosinophilia 01/2018
1	Cicatrix (Scar) 01/2018
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 08/2014
1	Esophageal Squamous Cell Carcinoma 09/2013
1	Infections 09/2012
1	Breast Neoplasms (Breast Cancer) 04/2012
1	Hematologic Neoplasms (Hematological Malignancy) 04/2012
1	Status Epilepticus (Complex Partial Status Epilepticus) 04/2009
1	Disease Progression 10/2008
1	Adenocarcinoma 09/2006
1	Constipation 09/2005
1	Hepatocellular Carcinoma (Hepatoma) 01/2004
1	Ascites 01/2004
1	Neoplasm Metastasis (Metastasis) 01/2004
1	Pleural Effusion (Pleural Effusions) 10/2002

3	ErbB Receptors (EGF Receptor)IBA 10/2008 - 12/2004
3	Phosphotransferases (Kinase)IBA 12/2007 - 12/2004
3	Gefitinib (Iressa)FDA Link 12/2007 - 12/2004
2	Immune Checkpoint InhibitorsIBA 01/2021 - 10/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2008 - 12/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2004 - 10/2002
1	Tacrolimus (Prograf)FDA LinkGeneric 12/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 12/2022
1	grazoprevirIBA 01/2022
1	Prostaglandins DIBA 01/2022
1	elbasvirIBA 01/2022
1	avelumabIBA 12/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	GlucocorticoidsIBA 10/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 09/2012
1	Small Interfering RNA (siRNA)IBA 09/2012
1	SodiumIBA 04/2009
1	Tyrosine Kinase InhibitorsIBA 10/2008
1	Threonine (L-Threonine)FDA Link 12/2007
1	Methionine (L-Methionine)FDA Link 12/2007
1	diallyl disulfide (diallyl disulphide)IBA 03/2006
1	PlasticsIBA 09/2005
1	Polyvinyl Chloride (PVC)IBA 09/2005
1	ParaffinIBA 12/2004
1	BilirubinIBA 01/2004
1	Fluorouracil (Carac)FDA LinkGeneric 01/2004
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2004
1	N-formylmethionylphenylalanine (FMP)IBA 01/2004
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2002

12	Terminal Care (Care, Terminal) 07/2022 - 06/2013
7	Cardiopulmonary Resuscitation (CPR) 07/2022 - 11/2017
6	Drug Therapy (Chemotherapy) 07/2022 - 10/2002
6	Artificial Respiration (Mechanical Ventilation) 07/2022 - 11/2017
5	Therapeutics 01/2022 - 01/2004
5	Enteral Nutrition (Feeding, Tube) 01/2022 - 11/2017
3	Hospice Care (Care, Bereavement) 07/2022 - 01/2022
3	Immunotherapy 07/2022 - 01/2018
2	Heart Massage 01/2019 - 11/2017
1	Chemoradiotherapy 01/2023
1	Resuscitation Orders (Do Not Resuscitate Orders) 12/2020
1	Nutritional Support (Artificial Feeding) 01/2019
1	Radiotherapy 01/2016
1	Neoadjuvant Therapy 09/2013
1	Urinary Catheters 09/2005
1	Institutionalization (Institutionalized Persons) 09/2005
1	FMP regimen 01/2004